The Thyroid Cancer market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Thyroid Cancer pipeline products will significantly revolutionize the Thyroid Cancer market dynamics.
Thyroid Cancer Overview
The thyroid, or thyroid gland, is an endocrine gland in the neck. It releases hormones that help control metabolism, heart rate, blood pressure, and body temperature. Thyroid cancer is a form of cancer that begins in the tissues of the thyroid gland. The major thyroid cancer types are differentiated (including Hürthle’s papillary, follicular and papillary), medullary, and anaplastic (aggressive form). Most thyroid cancers are differentiated cancers and when they are observed in the lab, the cells in these cancers appear a lot like normal thyroid tissue
Some of the key facts of the Thyroid Cancer Market Report:
- The Thyroid Cancer market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- As per Surveillance, Epidemiology, and End Results (SEER), Thyroid cancer accounts for 43,800 new cases in the United States; in 2022
- The rate of new cases of thyroid cancer was 15.7 per 100,000 men and women per year. The death rate was 0.5 per 100,000 men and women per year
- Key Thyroid Cancer Companies: Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology, AstraZeneca, and others
- Key Thyroid Cancer Therapies: Dabrafenib, Trametinib, AIC 100, LOXO-260, Durvalumaband, tremelimumab, and others
- The Thyroid cancer epidemiology based on gender analyzed that women are much more affected by Thyroid Cancer as compared to men
Get a Free sample for the Thyroid Cancer Market Report
Key benefits of the Thyroid Cancer Market report:
- Thyroid Cancer market report covers a descriptive overview and comprehensive insight of the Thyroid Cancer Epidemiology and Thyroid Cancer market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Thyroid Cancer market report provides insights on the current and emerging therapies.
- Thyroid Cancer market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Thyroid Cancer market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Thyroid Cancer market.
Discover more about therapies set to grab major Thyroid Cancer market share @ Thyroid Cancer market forecast
Thyroid Cancer Epidemiology Segmentation:
The Thyroid Cancer market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Thyroid Cancer
- Prevalent Cases of Thyroid Cancer by severity
- Gender-specific Prevalence of Thyroid Cancer
- Diagnosed Cases of Episodic and Chronic Thyroid Cancer
Thyroid Cancer Market
The dynamics of the Thyroid Cancer market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Dabrafenib, Trametinib, and others during the forecasted period 2019-2032.
Download the report to understand which factors are driving Thyroid Cancer epidemiology trends @ Thyroid Cancer Epidemiological Insights
Thyroid Cancer Market Strengths
- There are lot of approved therapies for thyroid cancer which is a major market mover
- The incidence rate of thyroid cancer has increased in the past which has lead to a higher patient pool
Thyroid Cancer Therapies and Key Companies
- Dabrafenib+Trametinib: Novartis
- AIC 100: AffyImmune Therapeutics
- LOXO-260: Eli Lilly + LoxoOncology
- Durvalumaband tremelimumab: AstraZeneca
Scope of the Thyroid Cancer Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Thyroid Cancer Companies: Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology, AstraZeneca, and others
- Key Thyroid Cancer Therapies: Dabrafenib, Trametinib, AIC 100, LOXO-260, Durvalumaband, tremelimumab, and others
- Therapeutic Assessment: Thyroid Cancer current marketed and Thyroid Cancer emerging therapies
- Thyroid Cancer Market Dynamics: Thyroid Cancer market drivers and Thyroid Cancer market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Unmet Needs, KOL’s views, Analyst’s views, Thyroid Cancer Market Access and Reimbursement
Thyroid Cancer Market Opportunities
- With the increasing global population, the incidence of thyroid cancer has also surged, leading to increased opportunities for research and development
Table of Contents
1. Thyroid Cancer Market Report Introduction
2. Executive Summary for Thyroid Cancer
3. SWOT analysis of Thyroid Cancer
4. Thyroid Cancer Patient Share (%) Overview at a Glance
5. Thyroid Cancer Market Overview at a Glance
6. Thyroid Cancer Disease Background and Overview
7. Thyroid Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Thyroid Cancer
9. Thyroid Cancer Current Treatment and Medical Practices
10. Thyroid Cancer Unmet Needs
11. Thyroid Cancer Emerging Therapies
12. Thyroid Cancer Market Outlook
13. Country-Wise Thyroid Cancer Market Analysis (2019–2032)
14. Thyroid Cancer Market Access and Reimbursement of Therapies
15. Thyroid Cancer Market drivers
16. Thyroid Cancer Market barriers
17. Thyroid Cancer Appendix
18. Thyroid Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
To know more about Thyroid Cancer treatment, visit @ Thyroid Cancer Medications
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/